Canada Markets closed

MedMen Enterprises Inc. (MMNFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1350-0.0084 (-5.86%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.1434
Open0.1330
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1310 - 0.1450
52 Week Range0.1310 - 1.4700
Volume4,091,105
Avg. Volume2,789,788
Market Cap164.087M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-0.2410
Earnings DateFeb. 14, 2022 - Feb. 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.32
  • Business Wire

    MedMen’s Tracy McCourt Appointed President of West Hollywood Cannabis Organization

    LOS ANGELES, January 13, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQB: MMNFF), a leading cannabis retailer with operations across the nation, today announced the appointment of Tracy McCourt, Chief Revenue Officer, to President of Emerald Village West Hollywood. Established in 2021, Emerald Village West Hollywood is the official marketing organization for licensed cannabis businesses in West Hollywood.

  • Business Wire

    MedMen Expands Brand Portfolio With Boutique Strains From Fog City Farms

    LOS ANGELES, January 11, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced it will carry new products from Fog City Farms, a Santa Cruz-based cannabis cultivation company specializing in sustainable growing and business practices, with an emphasis on boutique strains. Beginning January 23, unique small-batch strains cultivated in Fog City Farms’ state-of-the-art vertical growing pla

  • GlobeNewswire

    Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

    New Parent Company Name, TILRAY BRANDS, Reflects Growing Portfolio of Leading, Global CPG BrandsNet Revenue Increased ~20% to $155 Million from the Prior Year Quarter Net Income Improved $95 Million to $6 Million from the Prior Year QuarterAdjusted EBITDA of $13.8 Million, 11th Consecutive Quarter of Positive Adjusted EBITDAAchieved $70 Million in Cost Synergies To Date; On-Track to Exceed Original Plan of $80 Million Ahead of Schedule and to Generate Additional $20 Million of Synergies in Fisca